Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Novartis wins European approval for triple blood pressure pill

Faced with patent expiration for its top-selling Diovan (valsartan) blood pressure drug - which brought in $4.48bn in the first nine months of the year - Novartis has been turning to

Novartis hit by generic competition for Diovan in the UK as the drug's EU patents fall

Actavis launched generic versions of various formulations of Novartis' blood pressure drug Diovan in the UK yesterday, on the first day that patent protection expired across a number of EU member ... states. Diovan (valsartan) remains Novartis' biggest

Novartis closes three sites, cuts 2000 jobs

These include blood pressure treatment Diovan (valsartan), which is already feeling the effects of generic competition as patent protection is lost in stages over the next two years.

Novartis profits up by almost a third

Gleevic/Glivec (imatinib) and Diovan (valsartan) were the company's biggest sellers, making over $1bn each, although Diovan's sales are due to be affected by the launch of generic competition.

Valuable collection

C09 – Angiotensin II antagonists (Novartis' Diovan). •C10 – Serum lipid lowering agents (Pfizer's Lipitor).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics